Click Here to return To Results

 

Methylprednisolone in Multiple Sclerosis:A Comparison of Oral with Intravenous Therapy at Equivalent High Dose JNNP 56:1219-1220, Alam,S.M.,et al, 1993 See this aricle in Pubmed Article Abstract A randomised double-blind placebo-controlled trial of intravenous methylprednisolone versus oral methylprednisolone at equivalent high dose was carried out on 35 patients with an acute relapse of multiple sclerosis (MS).After baseline evaluation each was randomly allocated to oral treatment and intravenous placebo or intravenous treatment and oral placebo,receiving 500 mg of methylprednisolone for five consecutive days and with reassessment at days five and twenty-eight.There was no significant difference in response when disability or functional scores were compared in the two groups.Adverse effects were minor and equally distributed.In this study oral treatment with methylprednisolone was as effective as intravenous treatment in the acute relapse of MS.

Related Tags

(click to filter results - removes previous filter) dysgeusia metallic taste multiple sclerosis multiple sclerosis,treatment of steroid steroid therapy,CNS treatment and complications with treatment of neurologic disorder

Click Here to return To Results